San Diego, CA, United States of America

Chan Kou (Jack) Hwang

This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chan Kou (Jack) Hwang. Retrieved from https://idiyas.com/inventor/chan-kou-jack-hwang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees and patents, I'll be glad to assist you in creating an article about inventor Chan Kou (Jack) Hwang. Here is the structure you requested:

Title: The Innovative Work of Inventor Chan Kou (Jack) Hwang

Introduction:

In the vibrant city of San Diego, CA (US), inventor Chan Kou (Jack) Hwang is making waves in the field of pharmaceuticals with his groundbreaking patent innovations.

Latest Patents:

Chan Kou (Jack) Hwang's notable patent is on compounds having selective activity for retinoid X receptors, revolutionizing the modulation of processes mediated by these receptors. His patent includes compounds, compositions, and methods for effectively modulating processes mediated by Retinoid X Receptors.

Career Highlights:

Currently working at Ligand Pharmaceuticals, Inc., Chan Kou (Jack) Hwang leverages his expertise to push boundaries in the pharmaceutical industry. With a keen focus on retinoid X receptors, his work showcases a dedication to advancing drug discovery and development.

Collaborations:

Chan Kou (Jack) Hwang collaborates closely with esteemed coworkers such as Marcus F. Boehm and Richard Alan Heyman. Together, they form a dynamic team driving innovation and excellence in pharmaceutical research and development.

Conclusion:

In conclusion, Chan Kou (Jack) Hwang's pioneering work in the modulation of processes mediated by retinoid X receptors stands as a testament to his ingenuity and commitment to advancing pharmaceutical science. His contributions continue to inspire and shape the future of drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…